{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:36:39Z","timestamp":1795217799067,"version":"4.10.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijantimicag.2026.107716","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:15:16Z","timestamp":1767917716000},"page":"107716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics of ampicillin, sulbactam and combined ampicillin\/sulbactam in subcutis, muscle and plasma: A microdialysis trial in healthy volunteers"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-5878","authenticated-orcid":false,"given":"Anselm","family":"Jorda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Pracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7326-8310","authenticated-orcid":false,"given":"Marlene","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Leutzendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Pecho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1687-5296","authenticated-orcid":false,"given":"Maria","family":"Sanz-Codina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2168-2809","authenticated-orcid":false,"given":"Lukas","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0982-6068","authenticated-orcid":false,"given":"Edith","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2560-9598","authenticated-orcid":false,"given":"Christoph","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-1936","authenticated-orcid":false,"given":"Valentin","family":"al Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107716_bib0001","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-0691.2007.01847.x","article-title":"Sulbactam-containing beta-lactamase inhibitor combinations","volume":"14","author":"Akova","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0003","first-page":"1633","article-title":"Community-acquired pneumonia","volume":"389","author":"Arora","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0004","doi-asserted-by":"crossref","first-page":"e3687","DOI":"10.1002\/dmrr.3687","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","volume":"40","author":"Senneville","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0006","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.40.11.2468","article-title":"Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions","volume":"40","author":"Alexov","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0007","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/AAC.35.9.1772","article-title":"Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery","volume":"35","author":"Wildfeuer","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0008","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13054-018-2155-1","article-title":"Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients","volume":"22","author":"Veiga","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40262-014-0131-8","article-title":"Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions","volume":"53","author":"Azeredo","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/AAC.21.4.565","article-title":"Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration","volume":"21","author":"Brown","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0011","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST Clinical Breakpoint Tables v. 15.0. 2025; https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Dosages_v_15.0_Breakpoint_Tables.pdf. (Accessed December 1, 2025)"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0012","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/antibiotics11070923","article-title":"Protein binding in translational antimicrobial development-focus on interspecies differences","volume":"11","author":"Ahmed","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0013","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bcp.15564","article-title":"Effect of the human endotoxin challenge on tedizolid tissue penetration","volume":"89","author":"Jorda","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0014","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bcpt.13709","article-title":"Diclofenac in vitro microdialysis study comparing different experimental set-ups to improve quantitative recovery","volume":"130","author":"Jorda","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40262-025-01497-1","article-title":"Impact of hypothermic temperature control on plasma and soft tissue pharmacokinetics of penicillin\/beta-lactamase inhibitor combinations in patients resuscitated after cardiac arrest","volume":"64","author":"Stommel","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0016","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/17576180.2024.2365526","article-title":"Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables","volume":"16","author":"Lier","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0017","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4155\/bio.13.274","article-title":"The bioanalytical challenge of determining unbound concentration and protein binding for drugs","volume":"5","author":"Nilsson","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0018","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11095-006-9206-z","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives","volume":"24","author":"Chaurasia","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01248-22","article-title":"Model-informed clinical practice - determining an appropriate ampicillin-sulbactam redosing regimen in surgical patients by utilizing population pharmacokinetics and target attainment analysis","volume":"67","author":"Reeder","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40262-023-01219-5","article-title":"Population pharmacokinetics and dosing simulations of ampicillin and sulbactam in hospitalised adult patients","volume":"62","author":"Setiawan","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0021","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antimicrobial wild type distributions of microorganisms. 2025; https:\/\/mic.eucast.org\/search. (Accessed December 1, 2025)"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2026.107716_bib0022","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1093\/cid\/ciz002","article-title":"Current epidemiology, etiology, and burden of acute skin infections in the United States","volume":"68","author":"Kaye","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0023","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12879-024-09677-3","article-title":"Microbiological characterization of neuropathic diabetic foot infection: a retrospective study at a Portuguese tertiary hospital","volume":"24","author":"Goncalves","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0024","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s40262-024-01394-z","article-title":"Penetration of antibiotics into subcutaneous and intramuscular interstitial fluid: a meta-analysis of microdialysis studies in adults","volume":"63","author":"De Sutter","year":"2024","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 5","key":"10.1016\/j.ijantimicag.2026.107716_bib0025","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.1093\/clinids\/8.Supplement_5.503","article-title":"Pharmacokinetics of sulbactam\/ampicillin in humans: a review","volume":"8","author":"Foulds","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0026","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/AAC.03857-14","article-title":"Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model","volume":"59","author":"Tottrup","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0027","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bcp.12232","article-title":"Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment","volume":"77","author":"Soto","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0028","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0029","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/00003246-200006000-00009","article-title":"Surgery and intensive care procedures affect the target site distribution of piperacillin","volume":"28","author":"Brunner","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0030","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1093\/jac\/dkae359","article-title":"Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers","volume":"79","author":"Sanz-Codina","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0031","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2017.12.037","article-title":"OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam","volume":"537","author":"Wen","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0032","doi-asserted-by":"crossref","first-page":"107647","DOI":"10.1016\/j.pharmthera.2020.107647","article-title":"Regulation of organic anion transporters: role in physiology, pathophysiology, and drug elimination","volume":"217","author":"Zhang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0033","article-title":"Safety, pharmacokinetics, and drug-drug interaction potential of intravenous durlobactam, a \u03b2-lactamase inhibitor, in healthy subjects","volume":"64","author":"Lickliter Jason","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0034","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/rccm.202306-0974OC","article-title":"Antimicrobial drug penetration is enhanced by lung tissue inflammation and injury","volume":"209","author":"Geilen","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcpa.2017.10.001","article-title":"Suppurative inflammation and local tissue destruction reduce the penetration of cefuroxime to infected bone implant cavities","volume":"157","author":"Jensen","year":"2017","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.ijantimicag.2026.107716_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T14:33:54Z","timestamp":1779460434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0924857926000051"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107716","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of ampicillin, sulbactam and combined ampicillin\/sulbactam in subcutis, muscle and plasma: A microdialysis trial in healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107716"}}